VAXSYS VASCULAR WRAP
Angiotech Pharmaceuticals, Inc.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 77250183 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Domestic Representative | Kevin S. Costanza |
| Attorney Name | Kevin S. Costanza |
| Attorney Docket Number | 110129.20439 |
| Law Office Assigned | L20 |
| Employee Name | AGOSTO, GISELLE MARIE |
Timeline
| 2007-08-08 | Application Filed |
| 2008-06-03 | Published for Opposition |
| 2009-05-08 | Abandon |
| 2009-05-08 | Location: TTAB |
| 2009-05-08 | Status: Dead/Abandoned |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Angiotech Pharmaceuticals, Inc. |
| Address | 1618 Station Street Vancouver CA V6A1B6 |
| Legal Entity Type | Corporation |
| Legal Entity State | CA |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| Type Code | Type |
|---|---|
| D10000 | "VASCULAR WRAP" |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2007-08-13 | 1 NWAP I:Incoming Correspondence |
| NOTICE OF PSEUDO MARK MAILED | 2007-08-14 | 2 MPMK O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2007-11-14 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2007-11-16 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2007-11-16 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2007-11-16 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2008-04-30 | 7 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2008-04-30 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2008-04-30 | 9 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2008-05-01 | 10 CNSA P: |
| ASSIGNED TO LIE | 2008-05-01 | 11 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2008-05-01 | 12 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2008-05-14 | 13 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2008-06-03 | 14 PUBO A:Allowance for Publication |
| EXTENSION OF TIME TO OPPOSE RECEIVED | 2008-06-20 | 15 ETOF T:TTAB Proceeding |
| OPPOSITION INSTITUTED NO. 999999 | 2008-10-01 | 16 OP.I T:TTAB Proceeding |
| OPPOSITION SUSTAINED NO. 999999 | 2009-05-08 | 17 OP.S T:TTAB Proceeding |
| OPPOSITION TERMINATED NO. 999999 | 2009-05-08 | 18 OP.T T:TTAB Proceeding |
| ABANDONMENT - AFTER INTER PARTES DECISION | 2009-05-08 | 19 ABN4 O:Outgoing Correspondence |
| ABANDONMENT NOTICE MAILED - INTER PARTES DECISION | 2009-05-08 | 20 MAB4 O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 VAXSYS VASCULAR WRAP 77250183 not registered Dead/Abandoned |
Angiotech Pharmaceuticals, Inc. 2007-08-08 |
 VAXSYS VASCULAR WRAP 77250178 not registered Dead/Abandoned |
Angiotech Pharmaceuticals, Inc. 2007-08-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 